Diagnostics & Imaging

Wellysis S-Patch CardioAI

AI software that analyzes wearable patch ECG recordings to detect and classify arrhythmias.

The Signal

FDA 510(k) cleared as a Class II device on September 25, 2026, and can be built into remote monitoring and diagnostic testing platforms.

AI-driven triage and notification software for detecting acute abnormalities in medical imaging scans.

Care coordination platform using artificial intelligence to identify strokes and other vascular diseases.

AI-powered radiology solutions for detecting lung abnormalities and breast cancer on chest X-rays.

FDA-cleared digital pathology software utilizing artificial intelligence to assist pathologists in cancer detection.

Ambulatory cardiac monitoring service using wearable biosensors and cloud-based data analytics.

AI-powered pathology analysis tools for drug development and diagnostic accuracy in clinical trials.